Search
Johns Hopkins Medicine Celebrates Opening of The Johns Hopkins National Proton Center at Sibley Memorial Hospital, in Collaboration With Children’s National
Pediatric and adult cancer patients in the District of Columbia and elsewhere will now have access to one of the most advanced, lifesaving proton technologies offered in the U.S.The Big Reveal
New technologies at MUSC are poised to detect and diagnose lung cancer earlier and less invasively.Scleroderma Lung Disease: The Best Protocol for Early Detection and Treatment
Q&A with Fredrick M. Wigley, M.D., Founder and Director of the Johns Hopkins Scleroderma CenterUH Neurological Institute Concussion Training for the UH Physician - 2016
Expiration Date: May 9, 2019Long-Distance Medicine
MUSC is a leader in telemedicine, providing important services while also pioneering new, innovative programs to improve health care across the state.Research Advancements Focus on Biomarkers, Disease Management, COVID-19 and More
Despite the challenges posed by the COVID-19 pandemic, 2020 was an exciting year for researchers in the Johns Hopkins Division of Nephrology. Here are some of the high impact journal articles published by the team’s researchers in 2020.The Organ Donor, the Surgeon and a U.S. First for People Living with HIV
Nina Martinez and transplant surgeon Dorry Segev made history with the nation's first kidney donation from a person living with HIV.A Cancer Innovation Engine: 10 Roswell Park Research Advances to Look for in 2021
The past year has been a challenging one for so many of us. While the new coronavirus absorbed our attention, cancer has continued to take the lives of many around us. Early evidence suggests that the rates of death from cancer are likely to reverse their recent trend and start rising again as an indirect effect of COVID-19. At this pivotal moment, researchers from the labs and clinical centers at Roswell Park Comprehensive Cancer Center continue to tackle the most urgent priorities in oncology so that more people can survive another deadly disease.2019 Updated Cardiovascular Disease Prevention Guidelines Announced
Johns Hopkins cardiologists have released updated guidelines designed to prevent a first heart attack, stroke, heart failure and atrial fibrillation.UCSF and I-SPY 2 Breast Cancer Researchers Develop Newly Redefined Breast Cancer Response Subtypes
Research scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients.Mending a Broken Heart
MUSC has several innovative strategies to help patients quickly address and manage their heart conditions.Dana-Farber Research Publication 02.01.2023
This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.